Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 11 Issue 4, April 2005

Scanning electron micrograph of glomeruli in the human kidney. BMP agonists protect against renal fibrosis. In this issue, Dressler and colleagues (page 387) identify the first endogenous BMP enhancer and explore its role in kidney disease. SPL/Photo Researchers, Inc.

Editorial

Top of page ⤴

News

Top of page ⤴

Correspondence

Top of page ⤴

Book Review

Top of page ⤴

News & Views

  • The accumulation of fibroblasts in epithelial organs such as the kidney can produce dangerous scars. Such tissue fibrosis begins when epithelial cells morph into fibroblasts by epithelial-mesenchymal transition. A key regulator of this process in the kidney now emerges (pages 387–393).

    • Eric G Neilson
    News & Views
  • The force exerted by blood as it flows through the vessels influences the development of atherosclerosis. An understanding of how disturbed flow leads to disease is now emerging.

    • David G Harrison
    News & Views
  • A new mouse model begins to unravel a longstanding mystery: why are cancers often associated with blood coagulation disorders?

    • Olga I Stenina
    • Edward F Plow
    News & Views
  • THC acts as a pain reliever in part by engaging a receptor in peripheral tissues, CB2. But exactly where CB2 is and how it operates has been unclear. A new study shows that cannabinoids, acting through CB2 on skin cells, stimulate the local release of endogenous opioids.

    • Krisztina Monory
    • Beat Lutz
    News & Views
  • Blocking β-adrenergic receptors is a standard treatment for heart failure, but it limits the normal ability to modulate cardiac function. Targeting therapy further downstream by blocking activation of calcium-calmodulin–dependent protein kinase could provide an alternative (pages 409–407).

    • Donald M Bers
    News & Views
  • Immunotherapy for allergies can be an imperfect and unpredictable exercise; immunization with allergens can even lead to an acute allergic response. A new approach, involving fusing the allergen to a protein that modulates the immune response, could provide a more effective and safer alternative (pages 446–449).

    • Janet Kalesnikoff
    • Stephen J Galli
    News & Views
  • Mutations in NOD2, encoding an intracellular bacteria-sensing protein, have been associated recently with Crohn disease. Two studies in mice investigate how these mutations may affect innate immunity to microbes in the intestine and progression of disease.

    • Brian Kelsall
    News & Views
Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Technical Report

Top of page ⤴

Corrigendum

Top of page ⤴

Supplement

  • Vaccines are our best protection against infectious disease and offer hope as immunotherapeutic approaches for the treatment of allergy, autoimmunity, cancer and other diseases.

    Supplement
Top of page ⤴

Search

Quick links